calcitonine gene related peptide related peptide - Cgrpr gene

Ubrogepant

Understanding Calcitonin Gene-Related Peptide (CGRP): A Key Player in Vasodilation and Migraine

Calcitonin gene-related peptide (CGRP) is a fascinating and significant neuropeptide with diverse physiological roles, particularly in the context of vascular function and pain signalingCalcitonin Gene Related Peptide (CGRP). This 37-amino-acid peptide is derived from the calcitonin gene and is a member of the calcitonin peptide superfamily, which also includes calcitonin (CT) and amylin. The complexity of its gene expression is highlighted by tissue-specific alternative RNA splicing, leading to its distinct functions. Understanding calcitonin gene-related peptide is crucial for grasping its implication in various bodily processes and conditions, most notably migraine headachesCalcitonin Gene Related Peptide, Human. For cellular and molecular biology applications. Available in 1 mg..

Calcitonin gene-related peptide finds its origins in neurons located in both the central and peripheral nervous systems. Its physiological impact is substantial, with a well-established role as a potent vasodilator. This means that CGRP plays a critical role in expanding blood vessels, thereby influencing blood flow and pressure作者：DJ O'Halloran·1991·被引用次数：67—Calcitonin gene related peptide (CGRP) gets its odd name from the way it was first identified; its existence was predicted.. Indeed, calcitonin gene-related peptide is a potent vasodilator peptide that affects the autonomic nervous system, appetite suppression, gastric acid release, temperature homeostasis, and heart rate. While it has systemic functions, its association with migraine pathophysiology has brought it to the forefront of neurological research and therapeutic development.

The link between calcitonin gene-related peptide and migraine is particularly strong. Research indicates that elevated levels of CGRP are frequently observed during migraine attacks. When CGRP is released, it can trigger intense inflammation in the meninges, the protective coverings of the brain. For a significant portion of migraine sufferers, this inflammation is a key component in generating the debilitating pain associated with migraines.作者：MS Asghar·2016·被引用次数：38—Intravenous infusion ofcalcitonin-gene-related-peptide (CGRP) provokes headache and migraine in humans. Mechanisms underlying CGRP-induced headache are not ... Therefore, calcitonin gene-related peptide (CGRP) is a protein that helps control blood vessel expansion, and its dysregulation is implicated in migraine.

This strong connection has paved the way for innovative therapeutic strategies. CGRP inhibitors have emerged as a significant advancement in migraine treatment and prevention. These CGRP inhibitors are designed to target and block the action of calcitonin gene-related peptide. Generally, these therapies involve monoclonal antibodies (mAbs) that specifically target and neutralize CGRP or its receptor. Examples of such targeted therapies include fremanezumab, a humanized monoclonal antibody directed against human calcitonin-gene-related peptide, and eptinezumab. These therapies represent a paradigm shift, moving beyond symptomatic relief to addressing a fundamental biological mechanism of migraine.

Further research into the CGRP pathway has identified key molecular players. The calcitonin gene-related peptide receptor (CalCRL or CGRP receptor), often complexed with the receptor activity-modifying protein 1 (Ramp1), is critical for CGRP to exert its effects on target cells, including neurons and vascular smooth muscle.CALCA calcitonin related polypeptide alpha [ (human)] Genetic variations in Calcrl and Ramp1 have been linked to differences in CGRP signaling.

Beyond migraine, calcitonin gene-related peptide has other notable functions and potential research applications. Exogenous administration of calcitonin gene-related peptide (CGRP), for instance, has been found to provoke headache and migraine in human subjects, underscoring its central role. Furthermore, studies suggest that exogenous calcitonin gene-related peptide (CGRP) can have a protective effect on acute pancreatitis, indicating its therapeutic potential in other conditions. It's important to note that there are different forms of this peptide, with researchers studying variations like calcitonin gene-related peptide I precursor and beta-Calcitonin gene-related peptide.

In laboratory settings, Calcitonin Gene Related Peptide, Human is available for cellular and molecular biology applications, allowing scientists to further investigate its intricate mechanisms. The development of calcitonin gene-related peptide antagonists also reflects the growing understanding and therapeutic targeting of this peptideCalcitonin Gene Related Peptide, Human. For cellular and molecular biology applications. Available in 1 mg.. The discovery of the vasoactive neuropeptide calcitonin gene-related peptide (CGRP) and its role in migraine pathophysiology has indeed ushered in a new era in migraine research and treatment. Through ongoing research into calcitonin gene-related peptide, we continue to uncover its multifaceted influence on human health.